EuBiologics Co., Ltd. (KOSDAQ:206650)

South Korea flag South Korea · Delayed Price · Currency is KRW
14,950
-580 (-3.73%)
At close: Feb 27, 2026
22.44%
Market Cap 549.01B
Revenue (ttm) 96.04B
Net Income (ttm) 24.87B
Shares Out 36.72M
EPS (ttm) n/a
PE Ratio 22.08
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 839,859
Average Volume 977,653
Open 15,420
Previous Close 15,530
Day's Range 14,750 - 15,480
52-Week Range 10,000 - 17,700
Beta 0.41
RSI 62.81
Earnings Date Feb 2, 2026

About EuBiologics

EuBiologics Co., Ltd., a biopharmaceutical company, focuses on developing vaccines against global pandemic and bacterial vaccines primarily in South Korea. It offers inactivated oral cholera vaccine under the Euvichol, Euvichol-Plus, and Euvichol-S names; and EuCorVac-19, a recombinant protein vaccine. The company also provides EcML that is used as a vaccine adjuvant, directly activating antigen presenting cell expressing TLR 4 agonist, stimulating the production of cytokines and co-stimulatory molecules. In addition, it offers carrier protein ... [Read more]

Sector Healthcare
Founded 2010
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 206650
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.